UTT Urinary Tract Treatment Ltd.

About

Q&A

What is UTT Urinary Tract Treatment Ltd.'s primary focus?

UTT Urinary Tract Treatment Ltd. is an Israeli startup focused on enhancing the efficacy of bladder treatments by providing solutions for prolonged topical exposure of drugs for various urinary conditions.

When was UTT Urinary Tract Treatment Ltd. founded?

UTT Urinary Tract Treatment Ltd. was founded in 2023.

What proprietary technologies is UTT Urinary Tract Treatment Ltd. developing?

UTT Urinary Tract Treatment Ltd. is developing three proprietary technologies: a biodegradable sponge for targeted drug delivery to the bladder, a non-surgical chemo-ablation treatment (Chemo-Gel) for prostate cancer, and an in-dwelling magnetic bladder buoy (ULC) for leakage control.

What are the target markets for UTT Urinary Tract Treatment Ltd.'s solutions?

UTT Urinary Tract Treatment Ltd. targets markets including Urinary Tract Infections, Bladder Cancer, Prostate Cancer, Urinary Incontinence, Overactive Bladder, and Bladder Inflammation.

Who is a key executive at UTT Urinary Tract Treatment Ltd.?

Irene Zeitoun serves as the COO & Chief Research Officer at UTT Urinary Tract Treatment Ltd.

Where is UTT Urinary Tract Treatment Ltd. headquartered?

UTT Urinary Tract Treatment Ltd. is headquartered in Tel Aviv, Israel.

What is the primary sector of UTT Urinary Tract Treatment Ltd.?

UTT Urinary Tract Treatment Ltd.'s primary sector is Biotechnology.

What is the goal of UTT Urinary Tract Treatment Ltd.?

UTT Urinary Tract Treatment Ltd.'s goal is to offer a paradigm change in topical drug treatments and a dignified incontinence-control device.

Team · 4

Asher

Founder · Founder

Irene Zeitoun

COO & Chief Research Officer

Boris Rozenblit

Analytical R&D Manager

Dr. Shira Chatumi

Director

Sectors & technology